Uncategorised - European Medical Journal

Organ transplant cryopreservation

Organ Transplant Preservation Linked to Cryosolution Properties

Organ transplant cryopreservation may be influenced by solution properties, with higher glass transition temperatures linked to reduced tissue damage in experimental models.

CRISPR gene therapy

CRISPR Gene Therapy Shows Promise in Sickle Cell Disease

CRISPR gene therapy shows improved haemoglobin levels and reduced vaso occlusive events in severe sickle cell disease in early phase study data.

Pregnant patient discussing maternal RSV vaccination with a healthcare professional.

Maternal RSV Vaccination May Prevent Infant Hospitalization

Maternal RSV vaccination was linked to lower infant hospitalization as uptake gaps persisted across Dallas mothers.

Joint Physician-Nurse Session: Elordi García

I am a journalist, and when I was diagnosed with leukaemia in December 2013, I was presenting a morning magazine programme on a regional…

The Beginning of Women’s Heart Health

In this series, host Saranya Ravindran speaks with Nanette K. Wenger about the evolution of women’s cardiovascular health. From early…

Dermatology clinician performing a skin cancer screening examination for a patient.

Skin Cancer Screening Remains Inconsistent After Organ Transplant

Skin cancer screening remains inconsistent among solid organ transplant recipients, despite sharply elevated post-transplant malignancy risk.

Patient discussing fatigue and brain fog related to Sjögren’s disease with a physician.

Brain Fog Burden Emerges in Sjögren’s Disease

Sjögren’s disease may carry a substantial psychological burden, with depression, anxiety, fatigue, and brain fog affecting care.

COVID-19 Impact on Melanoma Incidence Trends - EMJ

COVID-19 Pandemic Linked to Drop in Melanoma Diagnoses

COVID-19 disrupted melanoma diagnoses, reducing early detection and shifting prognostic patterns across regions with different public health strategies.

Obinutuzumab Delivers Breakthrough in Lupus Control

Large phase 3 trial involving over 300 patients with active lupus, those treated with obinutuzumab achieved markedly higher response rates at one year. Nearly 77% of patients receiving the therapy met the primary endpoint

Genetic Breakthrough Reveals New Clues to Endometriosis Risk

Discover how new findings in endometriosis genetics could transform diagnosis and treatment.